These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20394542)

  • 61. Etiology of tearing in patients seen in an oculoplastic clinic in Saudi Arabia.
    Bukhari A
    Middle East Afr J Ophthalmol; 2013; 20(3):198-200. PubMed ID: 24014980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. External lacrimal punctum grading: reliability and interobserver variation.
    Kashkouli MB; Nilforushan N; Nojomi N; Rezaee R
    Eur J Ophthalmol; 2008; 18(4):507-11. PubMed ID: 18609466
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Pre-Sac Reflux Test (PSRT): a new diagnostic test for presaccal stenosis/obstruction.
    Park J; Kim H
    Graefes Arch Clin Exp Ophthalmol; 2016 Oct; 254(10):2057-2064. PubMed ID: 27582086
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Re: "Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel".
    Savar A; Esmaeli B
    Ophthalmic Plast Reconstr Surg; 2009; 25(5):418-9; author reply 419. PubMed ID: 19966671
    [No Abstract]   [Full Text] [Related]  

  • 65. The impact of available anti-glaucoma therapy on the volume and age profile of patients undergoing glaucoma filtration surgery.
    Keane PA; Khan MI; Saeed A; Stack J; Tormey P; Hayes P; Beatty S
    Eye (Lond); 2009 Aug; 23(8):1675-80. PubMed ID: 18978720
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Chinese expert consensus on ocular surface diseases related to topical glaucoma medications (2022)].
    Glaucoma Group of Ophthalmology Branch of Chinese Medical Association
    Zhonghua Yan Ke Za Zhi; 2022 Nov; 58(11):868-871. PubMed ID: 36348523
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of lacrimal drainage system in Pseudoexfoliation syndrome.
    Eroglu FC; Sekeroglu MA; Ceran TH; Simsek M; Hondur G
    Eye (Lond); 2022 Nov; 36(11):2094-2098. PubMed ID: 34645960
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Obstruction of the nasolacrimal duct by Ascaris lumbricoides.
    Cunha MC; Veloudios A; Dantas PE; Eagle RC
    Ophthalmic Plast Reconstr Surg; 1989; 5(2):141-3. PubMed ID: 2487208
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The need for artificial tears in glaucoma patients: a comparative, retrospective study.
    Costa VP; da Silva RS; Ambrósio R
    Arq Bras Oftalmol; 2013; 76(1):6-9. PubMed ID: 23812518
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Improper topical self-administration of ocular medication among patients with glaucoma.
    Brown MM; Brown GC; Spaeth GL
    Can J Ophthalmol; 1984 Feb; 19(1):2-5. PubMed ID: 6608974
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel.
    McCartney E; Valluri S; Rushing D; Burgett R
    Ophthalmic Plast Reconstr Surg; 2007; 23(2):170-1. PubMed ID: 17413646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Punctal stenosis in 6 dogs following the long-term use of topical neomycin-polymyxin B-dexamethasone.
    Quantz K; Stiles J
    Vet Ophthalmol; 2019 Mar; 22(2):196-200. PubMed ID: 30211477
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CORTICOSTEROIDS AND FIBROLYSIN IN THE PREVENTION OF LACRIMAL DUCT OBSTRUCTION.
    Dayal Y
    Br J Ophthalmol; 1962 Jan; 46(1):27-30. PubMed ID: 18170750
    [No Abstract]   [Full Text] [Related]  

  • 74. Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
    Soltau JB
    J Glaucoma; 2004 Aug; 13(4):348; author reply 348. PubMed ID: 15226666
    [No Abstract]   [Full Text] [Related]  

  • 75. Does lacrimal duct occlusion decrease intraocular pressure in patients refractory to medical treatment for glaucoma? A randomized, sham-controlled, crossover trial.
    Simel DL; Simel PJ
    J Clin Epidemiol; 1988; 41(9):859-65. PubMed ID: 3183692
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Predisposing factors for primary acquired nasolacrimal duct obstruction.
    Ohtomo K; Ueta T; Toyama T; Nagahara M
    Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1835-9. PubMed ID: 23446557
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Associated morbidity of nasolacrimal duct obstruction--a large community based case-control study.
    Nemet AY; Vinker S
    Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):125-30. PubMed ID: 24146269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Systemic drug interactions with topical glaucoma medications.
    Gerber SL; Cantor LB; Brater DC
    Surv Ophthalmol; 1990; 35(3):205-18. PubMed ID: 1980380
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Punctal Stenosis Associated with Topical Netarsudil Use.
    Meirick TM; Mudumbai RC; Zhang MM; Chen PP
    Ophthalmology; 2022 Jul; 129(7):765-770. PubMed ID: 35231471
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Do selective topical beta antagonists for glaucoma have respiratory side effects?
    Kirwan JF; Nightingale JA; Bunce C; Wormald R
    Br J Ophthalmol; 2004 Feb; 88(2):196-8. PubMed ID: 14736772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.